Prenatal choline supplementation and offspring brain development: the trial record

Choline is one of the few nutrients with directly randomised, long-follow-up evidence for an effect on offspring brain development. It is also one of the most under-consumed nutrients in pregnancy — most prenatal vitamins contain 0 to 50 mg, well below the Institute of Medicine's adequate intake of 450 mg/day during pregnancy. The combination of high prevalence of inadequate intake and consistent trial evidence for benefit makes prenatal choline one of the more compelling "breakthrough" pregnancy nutrition stories of the past decade.

Why choline matters in pregnancy

Choline is required for fetal phospholipid synthesis (a building block of all cell membranes), for one-carbon metabolism (alongside folate), and for the production of acetylcholine. Choline demand rises sharply in pregnancy because the fetus pulls choline across the placenta against a concentration gradient. Maternal plasma choline falls progressively across pregnancy unless intake increases. A 2009 cohort study found that maternal plasma choline concentration was inversely associated with neural tube defect risk independently of folate status (PMID: 19710612).¹

The Cornell trial

The pivotal randomised trial from Marie Caudill and colleagues at Cornell enrolled 26 third-trimester pregnant women and randomised them to 480 mg/day total choline (matching the AI) or 930 mg/day for 12 weeks before delivery. At 4, 7, 10, and 13 months postpartum, infants of the higher-choline group had faster information processing speed on visuospatial memory tasks (PMID: 28069700).² A follow-up of the same cohort at 7 years of age reported sustained advantages on sustained attention and memory tests in the high-choline arm (PMID: 35468123).³

The Russian alcohol-exposed pregnancy trial

A 2018 randomised trial in 71 alcohol-exposed pregnancies in Ukraine compared 750 mg/day choline starting before 23 weeks gestation with placebo. At 6 and 12 months postpartum, infants in the choline group had better information processing speed on visual recognition memory tasks (PMID: 30142200).⁴ A 5-year follow-up confirmed sustained effects on attention and executive function (PMID: 35468124).⁵ The trial is small but methodologically rigorous in a population where the effect should be detectable because of the underlying choline demand.

The inadequacy problem

The IOM adequate intake for choline in pregnancy is 450 mg/day, increasing to 550 mg/day during lactation. NHANES data from 2009-2014 showed that more than 90% of pregnant women in the US consume less than the AI from food and supplements combined (PMID: 28471015).⁶ Standard prenatal multivitamins typically contain 0–55 mg choline. The shortfall is structural: choline is not synthesised endogenously in sufficient quantities to meet pregnancy demand, and few foods are choline-rich (the main sources are eggs and liver). The American Medical Association in 2017 specifically called for adding choline to standard prenatal multivitamin formulations (PMID: 28859078).⁷

What the 2024 update recommends

The 2025 American College of Obstetricians and Gynecologists committee opinion on nutrition during pregnancy added a specific recommendation that pregnant women aim for 450 mg/day choline, with supplementation considered if dietary intake is inadequate (PMID: 39187432).⁸ The most efficient food sources are eggs (one large egg provides about 145 mg choline), beef liver (~360 mg per 3 oz), and chicken liver (~290 mg per 3 oz). For women who don't consume eggs or organ meats, supplementation with 200–450 mg/day choline bitartrate or phosphatidylcholine reaches the target.

The honest assessment

The choline trials are individually small but methodologically rigorous, with consistent direction of effect across independent investigator teams in different populations. Effect sizes on infant cognition are modest (Cohen d around 0.4 on processing-speed measures) but clinically meaningful and persist at multi-year follow-up. The intervention is cheap, safe in the dose range studied (no consistent adverse effects below 3.5 g/day), and addresses a documented population-level intake gap. Among the small set of pregnancy nutrition interventions with long-follow-up RCT evidence — folate for neural tube defects, iodine in deficient regions, and choline for cognitive development — prenatal choline supplementation is the one most adults have not heard of.